Subsequently, they found that E26 transformation-specific-1 (Ets-1) promotes the activity of JunB promoter, which depended on CD30 or NPM-ALK-ERK1/2 MAPK pathway in HL and ALCL(Watanabe et al., 2012). The gene discussed is MAPK3; the disease is anaplastic large cell lymphoma.